Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses

PLoS Pathog. 2022 Jun 3;18(6):e1010593. doi: 10.1371/journal.ppat.1010593. eCollection 2022 Jun.

Abstract

Flaviviruses, which are globally distributed and cause a spectrum of potentially severe illnesses, pose a major threat to public health. Although Flaviviridae viruses, including flaviviruses, possess similar genome structures, only the flaviviruses encode the non-structural protein NS1, which resides in the endoplasmic reticulum (ER) and is secreted from cells after oligomerization. The ER-resident NS1 is known to be involved in viral genome replication, but the essential roles of secretory NS1 in the virus life cycle are not fully understood. Here we characterized the roles of secretory NS1 in the particle formation of flaviviruses. We first identified an amino acid residue essential for the NS1 secretion but not for viral genome replication by using protein-protein interaction network analyses and mutagenesis scanning. By using the recombinant flaviviruses carrying the identified NS1 mutation, we clarified that the mutant flaviviruses employed viral genome replication. We then constructed a recombinant NS1 with the identified mutation and demonstrated by physicochemical assays that the mutant NS1 was unable to form a proper oligomer or associate with liposomes. Finally, we showed that the functions of NS1 that were lost by the identified mutation could be compensated for by the in trans-expression of Erns of pestiviruses and host exchangeable apolipoproteins, which participate in the infectious particle formation of pestiviruses and hepaciviruses in the family Flaviviridae, respectively. Collectively, our study suggests that secretory NS1 plays a role in the particle formation of flaviviruses through its interaction with the lipid membrane.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Flaviviridae*
  • Flavivirus* / genetics
  • Flavivirus* / metabolism
  • Glycoproteins
  • Viral Nonstructural Proteins / metabolism
  • Virus Replication

Substances

  • Glycoproteins
  • Viral Nonstructural Proteins

Grants and funding

Yoshiharu Matsuura was supported by the Ministry of Education, Culture, Sports, Science and Technology award numbers JP16H064320, JP16H064321, JP16H064322 and JP16H064323 (MEXT, http://www.mext.go.jp/) and by the Japan Science and Technology Agency award number JPMJMS2025 (JST Moonshot R&D, https://www.jst.go.jp/). T.F. was supported by the Japan Agency for Medical Research and Development (AMED, the Research Program on Emerging and Re-emerging Infectious Diseases, http://www.amed.go.jp/) award number JP16H064324. T. T. was supported by the Japan Society for the Promotion of Science (JSPS, Research Fellowships for young scientists, https://www.jsps.go.jp/) award number JP16J02628. Shiho Torii was supported by the Japan Society for the Promotion of Science (JSPS, Research Fellowships for young scientists, https://www.jsps.go.jp/) award number 19J12641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.